<?xml version="1.0" encoding="UTF-8"?><ns2:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:ns2="http://www.sec.gov/edgar/ownership">
    <ns2:headerData>
        <ns2:submissionType>144</ns2:submissionType>
        <ns2:filerInfo>
            <ns2:filer>
                <ns2:filerCredentials>
                    <ns2:cik>0001907056</ns2:cik>
                    <ns2:ccc>XXXXXXXX</ns2:ccc>
                </ns2:filerCredentials>
            </ns2:filer>
            <ns2:liveTestFlag>LIVE</ns2:liveTestFlag>



        </ns2:filerInfo>
    </ns2:headerData>
    <ns2:formData>
        <ns2:issuerInfo>
            <ns2:issuerCik>0001773751</ns2:issuerCik>
            <ns2:issuerName>Hims &amp; Hers Health, Inc.</ns2:issuerName>
            <ns2:secFileNumber>001-38986</ns2:secFileNumber>
            <ns2:issuerAddress>
                <com:street1>2269 Chestnut Street</com:street1>
                <com:street2>Suite 523</com:street2>
                <com:city>San Francisco</com:city>
                <com:stateOrCountry>CA</com:stateOrCountry>
                <com:zipCode>94123</com:zipCode>
            </ns2:issuerAddress>
            <ns2:issuerContactPhone>1-213-830-6300</ns2:issuerContactPhone>
            <ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Oluyemi Okupe</ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <ns2:relationshipsToIssuer>
                <ns2:relationshipToIssuer>Officer</ns2:relationshipToIssuer>
            </ns2:relationshipsToIssuer>
        </ns2:issuerInfo>
        <ns2:securitiesInformation>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:brokerOrMarketmakerDetails>
                <ns2:name>Goldman Sachs &amp; Co. LLC</ns2:name>
                <ns2:address>
                    <com:street1>200 West Street</com:street1>
                    <com:city>New York</com:city>
                    <com:stateOrCountry>NY</com:stateOrCountry>
                    <com:zipCode>10282</com:zipCode>
                </ns2:address>
            </ns2:brokerOrMarketmakerDetails>
            <ns2:noOfUnitsSold>110710</ns2:noOfUnitsSold>
            <ns2:aggregateMarketValue>1627437</ns2:aggregateMarketValue>
            <ns2:noOfUnitsOutstanding>205872690</ns2:noOfUnitsOutstanding>
            <ns2:approxSaleDate>03/04/2024</ns2:approxSaleDate>
            <ns2:securitiesExchangeName>NYSE</ns2:securitiesExchangeName>
        </ns2:securitiesInformation>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:acquiredDate>03/15/2023</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Restricted Stock Units</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>20094</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>03/15/2023</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:acquiredDate>02/24/2022</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Restricted Stock Units</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>22005</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>02/24/2022</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:acquiredDate>02/24/2022</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired as compensation -- Stock Options</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Issuer</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>68611</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>02/24/2022</ns2:paymentDate>
            <ns2:natureOfPayment>Compensation -- Cashless exercise/same day sale</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>N</ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Oluyemi Okupe</ns2:name>
                <ns2:address>
                    <com:street1>2269 Chestnut Street</com:street1>
                    <com:street2>Suite 523</com:street2>
                    <com:city>San Francisco</com:city>
                    <com:stateOrCountry>CA</com:stateOrCountry>
                    <com:zipCode>94123</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:saleDate>12/20/2023</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>3392</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>29236.33</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Oluyemi Okupe</ns2:name>
                <ns2:address>
                    <com:street1>2269 Chestnut Street</com:street1>
                    <com:street2>Suite 523</com:street2>
                    <com:city>San Francisco</com:city>
                    <com:stateOrCountry>CA</com:stateOrCountry>
                    <com:zipCode>94123</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:saleDate>02/12/2024</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>31363</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>314639.89</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Oluyemi Okupe</ns2:name>
                <ns2:address>
                    <com:street1>2269 Chestnut Street</com:street1>
                    <com:street2>Suite 523</com:street2>
                    <com:city>San Francisco</com:city>
                    <com:stateOrCountry>CA</com:stateOrCountry>
                    <com:zipCode>94123</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:saleDate>12/20/2023</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>3392</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>28967.68</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:securitiesSoldInPast3Months>
            <ns2:sellerDetails>
                <ns2:name>Oluyemi Okupe</ns2:name>
                <ns2:address>
                    <com:street1>2269 Chestnut Street</com:street1>
                    <com:street2>Suite 523</com:street2>
                    <com:city>San Francisco</com:city>
                    <com:stateOrCountry>CA</com:stateOrCountry>
                    <com:zipCode>94123</com:zipCode>
                </ns2:address>
            </ns2:sellerDetails>
            <ns2:securitiesClassTitle>Common</ns2:securitiesClassTitle>
            <ns2:saleDate>02/09/2024</ns2:saleDate>
            <ns2:amountOfSecuritiesSold>8509</ns2:amountOfSecuritiesSold>
            <ns2:grossProceeds>85344.42</ns2:grossProceeds>
        </ns2:securitiesSoldInPast3Months>
        <ns2:remarks>The sales of shares set forth herein are made in connection with a selling plan dated May 10, 2023 that is intended to comply with Rule 10b5-1(c)</ns2:remarks>
        <ns2:noticeSignature>
            <ns2:noticeDate>03/04/2024</ns2:noticeDate>
            <ns2:planAdoptionDates>
                <ns2:planAdoptionDate>05/10/2023</ns2:planAdoptionDate>
            </ns2:planAdoptionDates>
            <ns2:signature>Goldman Sachs &amp; Co. LLC on behalf of Oluyemi Okupe</ns2:signature>
        </ns2:noticeSignature>
    </ns2:formData>
</ns2:edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 8568}]
144
0001907056
XXXXXXXX
LIVE
0001773751
Hims & Hers Health, Inc.
001-38986
2269 Chestnut Street
Suite 523
San Francisco
CA
94123
1-213-830-6300
Oluyemi Okupe
Officer
Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
110710
1627437
205872690
03/04/2024
NYSE
Common
03/15/2023
Acquired as compensation -- Restricted Stock Units
Issuer
N
20094
03/15/2023
Compensation
Common
02/24/2022
Acquired as compensation -- Restricted Stock Units
issuer
N
22005
02/24/2022
Compensation
Common
02/24/2022
Acquired as compensation -- Stock Options
Issuer
N
68611
02/24/2022
Compensation -- Cashless exercise/same day sale
N
Oluyemi Okupe
2269 Chestnut Street
Suite 523
San Francisco
CA
94123
Common
12/20/2023
3392
29236.33
Oluyemi Okupe
2269 Chestnut Street
Suite 523
San Francisco
CA
94123
Common
02/12/2024
31363
314639.89
Oluyemi Okupe
2269 Chestnut Street
Suite 523
San Francisco
CA
94123
Common
12/20/2023
3392
28967.68
Oluyemi Okupe
2269 Chestnut Street
Suite 523
San Francisco
CA
94123
Common
02/09/2024
8509
85344.42
The sales of shares set forth herein are made in connection with a selling plan dated May 10, 2023 that is intended to comply with Rule 10b5-1(c)
03/04/2024
05/10/2023
Goldman Sachs & Co. LLC on behalf of Oluyemi Okupe